Showing results (11-20 of 128) with videos related to
Sort By:
Pageof 13
Current Opinion in Oncology|December 2, 2010
Biomarkers of DNA repair and related pathways: significance in non-small cell lung cancerSacha I Rothschild, Oliver Gautschi, Primo N Lara, et al.Current Drug Targets|October 21, 2009
Intercalation of erlotinib and pemetrexed in the treatment of non-small cell lung cancerTianhong Li, Primo N Lara, Philip C Mack, et al.Pediatric Blood & Cancer|July 29, 2011
Anti-tumor activity of the HSP90 inhibitor SNX-2112 in pediatric cancer cell linesDanielle C Chinn, William S Holland, Janet M Yoon, et al.Clinical Lung Cancer|October 10, 2006
Aurora kinase inhibitors: a new class of targeted drugs in cancerOliver Gautschi, Philip C Mack, Angela M Davies, et al.Lung Cancer (Amsterdam, Netherlands)|July 18, 2003
Integration of the proteasome inhibitor PS-341 (Velcade) into the therapeutic approach to lung cancerPhilip C Mack, Angela M Davies, Primo N Lara, et al.Free Radical Biology & Medicine|April 7, 2009
Multidrug-resistant protein-3 gene regulation by the transcription factor Nrf2 in human bronchial epithelial and non-small-cell lung carcinomaChristopher M Mahaffey, Hongqiao Zhang, Alessandra Rinna, et al.Molecular Cancer Therapeutics|December 17, 2011
Inhibition of dUTPase induces synthetic lethality with thymidylate synthase-targeted therapies in non-small cell lung cancerPeter M Wilson, Melissa J LaBonte, Heinz-Josef Lenz, et al.Journal of Cancer Research and Clinical Oncology|October 18, 2014
Effects of AKT inhibition on HGF-mediated erlotinib resistance in non-small cell lung cancer cell linesWilliam S Holland, Danielle C Chinn, Primo N Lara, et al.Clinical Lung Cancer|May 8, 2009
Pharmacogenomic approaches to individualizing chemotherapy for non-small-cell lung cancer: current status and new directionsOliver Gautschi, Philip C Mack, Angela M Davies, et al.Clinical Lung Cancer|May 19, 2023
Predictive Capability of PD-L1 Protein Expression for Patients With Advanced NSCLC: Any Differences Based on Histology?Noy Meshulami, Sooyun Tavolacci, Diego de Miguel-Perez, et al.Pageof 13